Increased lysosomal GM2 and reduced GM3 ganglioside in the patient's cultured fibroblasts.
(A) Fibroblasts from the patient and two normal healthy controls cultured on glass coverslips were fixed and stained with monoclonal humanized anti-GM2 and mouse anti-LAMP-2 antibodies followed by anti-human IgG Alexa 488-labeled (green) and anti-mouse IgG Alexa 555-labeled (red) secondary antibodies. Nuclei were stained with Draq5 (blue). The patient's fibroblasts show a higher intensity of GM2 staining (green) than control fibroblasts and increased co-localization of GM2 and LAMP-2 staining.
(B) Fibroblasts from the patient and two normal healthy controls were stained with monoclonal mouse anti-GM3 antibody followed by anti-mouse IgG Alexa-555-labeled secondary antibody (red). Nuclei were stained with Draq5 (blue).
The images were acquired in a Leica SP8 confocal microscope with a 63 × objective. Bar represents 10 μM. The panels show representative images of at least 40 studied for each cell type.
(C) Mean GM2 and GM3 staining intensity and a fraction of GM2-positive cells in control and patient's fibroblasts. Mean staining intensities per μm2 were measured with ImageJ software. Data show mean (± SEM) of individual values measured for 35 randomly selected cells. **P < 0.01, *P < 0.05 in unpaired two-tailed t-test. GM2-positive cells were manually counted in three randomly selected microscope fields (~ 150 cells each). Data show mean values (± SEM) of 3 independent experiments. *P < 0.05 in unpaired two-tailed t-test. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)